GOVX Relative Valuation
GOVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, GOVX is overvalued; if below, it's undervalued.
Historical Valuation
GeoVax Labs Inc (GOVX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.56. The fair price of GeoVax Labs Inc (GOVX) is between -- to -- according to relative valuation methord.
Relative Value
Fair Zone
-----
Current Price:0.18
Fair
-0.14
PE
1Y
3Y
5Y
0.00
EV/EBITDA
GeoVax Labs Inc. (GOVX) has a current EV/EBITDA of 0.00. The 5-year average EV/EBITDA is -0.41. The thresholds are as follows: Strongly Undervalued below -6.18, Undervalued between -6.18 and -3.30, Fairly Valued between 2.48 and -3.30, Overvalued between 2.48 and 5.36, and Strongly Overvalued above 5.36. The current Forward EV/EBITDA of 0.00 falls within the Historic Trend Line -Fairly Valued range.
-0.05
EV/EBIT
GeoVax Labs Inc. (GOVX) has a current EV/EBIT of -0.05. The 5-year average EV/EBIT is -0.35. The thresholds are as follows: Strongly Undervalued below -2.23, Undervalued between -2.23 and -1.29, Fairly Valued between 0.58 and -1.29, Overvalued between 0.58 and 1.52, and Strongly Overvalued above 1.52. The current Forward EV/EBIT of -0.05 falls within the Historic Trend Line -Fairly Valued range.
0.00
PS
GeoVax Labs Inc. (GOVX) has a current PS of 0.00. The 5-year average PS is 56.14. The thresholds are as follows: Strongly Undervalued below -179.99, Undervalued between -179.99 and -61.92, Fairly Valued between 174.21 and -61.92, Overvalued between 174.21 and 292.28, and Strongly Overvalued above 292.28. The current Forward PS of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/OCF
GeoVax Labs Inc. (GOVX) has a current P/OCF of 0.00. The 5-year average P/OCF is -1.10. The thresholds are as follows: Strongly Undervalued below -7.40, Undervalued between -7.40 and -4.25, Fairly Valued between 2.06 and -4.25, Overvalued between 2.06 and 5.21, and Strongly Overvalued above 5.21. The current Forward P/OCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
0.00
P/FCF
GeoVax Labs Inc. (GOVX) has a current P/FCF of 0.00. The 5-year average P/FCF is -1.32. The thresholds are as follows: Strongly Undervalued below -7.27, Undervalued between -7.27 and -4.29, Fairly Valued between 1.66 and -4.29, Overvalued between 1.66 and 4.63, and Strongly Overvalued above 4.63. The current Forward P/FCF of 0.00 falls within the Historic Trend Line -Fairly Valued range.
GeoVax Labs Inc (GOVX) has a current Price-to-Book (P/B) ratio of 1.25. Compared to its 3-year average P/B ratio of 97.64 , the current P/B ratio is approximately -98.72% higher. Relative to its 5-year average P/B ratio of 58.81, the current P/B ratio is about -97.87% higher. GeoVax Labs Inc (GOVX) has a Forward Free Cash Flow (FCF) yield of approximately -395.08%. Compared to its 3-year average FCF yield of -212.93%, the current FCF yield is approximately 85.54% lower. Relative to its 5-year average FCF yield of -151.06% , the current FCF yield is about 161.54% lower.
1.25
P/B
Median3y
97.64
Median5y
58.81
-395.08
FCF Yield
Median3y
-212.93
Median5y
-151.06
Competitors Valuation Multiple
The average P/S ratio for GOVX's competitors is 277.54, providing a benchmark for relative valuation. GeoVax Labs Inc Corp (GOVX) exhibits a P/S ratio of 0.00, which is -100% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
Performance Decomposition
1Y
3Y
5Y
Market capitalization of GOVX decreased by 89.34% over the past 1 year. The primary factor behind the change was an decrease in Margin Expansion from -208.48 to -684.83.
The secondary factor is the Revenue Growth, contributed -100.00%to the performance.
Overall, the performance of GOVX in the past 1 year is driven by Margin Expansion. Which is more sustainable.
People Also Watch
Frequently Asked Questions
Is GeoVax Labs Inc (GOVX) currently overvalued or undervalued?
GeoVax Labs Inc (GOVX) is now in the Fair zone, suggesting that its current forward PS ratio of 0.00 is considered Fairly compared with the five-year average of -1.56. The fair price of GeoVax Labs Inc (GOVX) is between to according to relative valuation methord.
What is GeoVax Labs Inc (GOVX) fair value?
GOVX's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of GeoVax Labs Inc (GOVX) is between to according to relative valuation methord.
How does GOVX's valuation metrics compare to the industry average?
The average P/S ratio for GOVX's competitors is 277.54, providing a benchmark for relative valuation. GeoVax Labs Inc Corp (GOVX) exhibits a P/S ratio of 0.00, which is -100.00% above the industry average. Given its robust revenue growth of -100.00%, this premium appears unsustainable.
What is the current P/B ratio for GeoVax Labs Inc (GOVX) as of Jan 09 2026?
As of Jan 09 2026, GeoVax Labs Inc (GOVX) has a P/B ratio of 1.25. This indicates that the market values GOVX at 1.25 times its book value.
What is the current FCF Yield for GeoVax Labs Inc (GOVX) as of Jan 09 2026?
As of Jan 09 2026, GeoVax Labs Inc (GOVX) has a FCF Yield of -395.08%. This means that for every dollar of GeoVax Labs Inc’s market capitalization, the company generates -395.08 cents in free cash flow.
What is the current Forward P/E ratio for GeoVax Labs Inc (GOVX) as of Jan 09 2026?
As of Jan 09 2026, GeoVax Labs Inc (GOVX) has a Forward P/E ratio of -0.14. This means the market is willing to pay $-0.14 for every dollar of GeoVax Labs Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for GeoVax Labs Inc (GOVX) as of Jan 09 2026?
As of Jan 09 2026, GeoVax Labs Inc (GOVX) has a Forward P/S ratio of 0.00. This means the market is valuing GOVX at $0.00 for every dollar of expected revenue over the next 12 months.